Correlation Between Aerovate Therapeutics and Partner Communications

Can any of the company-specific risk be diversified away by investing in both Aerovate Therapeutics and Partner Communications at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Aerovate Therapeutics and Partner Communications into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Aerovate Therapeutics and Partner Communications, you can compare the effects of market volatilities on Aerovate Therapeutics and Partner Communications and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Aerovate Therapeutics with a short position of Partner Communications. Check out your portfolio center. Please also check ongoing floating volatility patterns of Aerovate Therapeutics and Partner Communications.

Diversification Opportunities for Aerovate Therapeutics and Partner Communications

0.0

Correlation Coefficient

Aerovate Therapeutics  Partner Communications

Pay attention - limited upside

The 3 months correlation between Aerovate and Partner is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Aerovate Therapeutics and Partner Communications in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Partner Communications and Aerovate Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Aerovate Therapeutics are associated (or correlated) with Partner Communications. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Partner Communications has no effect on the direction of Aerovate Therapeutics i.e., Aerovate Therapeutics and Partner Communications go up and down completely randomly.

Pair Corralation between Aerovate Therapeutics and Partner Communications

If you would invest (100.00) in Partner Communications on December 5, 2024 and sell it today you would earn a total of  100.00  from holding Partner Communications or generate -100.0% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

Aerovate Therapeutics  vs.  Partner Communications

Aerovate Therapeutics

Risk-Adjusted Performance

Very Weak

Over the last 90 days Aerovate Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound basic indicators, Aerovate Therapeutics is not utilizing all of its potentials. The current stock price tumult, may contribute to shorter-term losses for the shareholders.

Partner Communications

Risk-Adjusted Performance

Very Weak

Over the last 90 days Partner Communications has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Partner Communications is not utilizing all of its potentials. The newest stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Aerovate Therapeutics and Partner Communications

The main advantage of trading using opposite Aerovate Therapeutics and Partner Communications positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Aerovate Therapeutics position performs unexpectedly, Partner Communications can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Partner Communications will offset losses from the drop in Partner Communications' long position.

The idea behind Aerovate Therapeutics and Partner Communications pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio File Import module to quickly import all of your third-party portfolios from your local drive in csv format.